Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -103.04% is 45% below its 5-year average of -70.96%, near the low end of its 5-year range (-126.62%–-10.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.09% below its 12-month average of -86.52%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -103.04%.
RETURN ON INVESTED CAPITAL (ROIC)
-103.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-86.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-75.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-70.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-72.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.09%
CURRENT VS 3Y AVG
-35.71%
CURRENT VS 5Y AVG
-45.20%
CURRENT VS 10Y AVG
-41.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
-199.22%
vs the sector median at left
Seres Therapeutics, Inc.
Market Cap
$27.78M
Return on Invested Capital (ROIC)
-103.04%
TTM Avg
-86.52%
3Y Avg
-75.92%
5Y Avg
-70.96%
Market Cap
$28.10M
Return on Invested Capital (ROIC)
-153.04%
TTM Avg
-84.65%
3Y Avg
-78.92%
5Y Avg
-71.84%
Market Cap
$28.49M
Return on Invested Capital (ROIC)
-109.29%
TTM Avg
-89.70%
3Y Avg
-72.19%
5Y Avg
-61.37%
Market Cap
$29.16M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.37M
Return on Invested Capital (ROIC)
-99.36%
TTM Avg
-324.14%
3Y Avg
-260.84%
5Y Avg
-230.57%
Market Cap
$29.58M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-48.51%
3Y Avg
-88.12%
5Y Avg
-74.86%
Market Cap
$30.09M
Return on Invested Capital (ROIC)
-42.23%
TTM Avg
-23.50%
3Y Avg
-191.16%
5Y Avg
-191.16%
Market Cap
$30.14M
Return on Invested Capital (ROIC)
-135.73%
TTM Avg
-98.73%
3Y Avg
-101.28%
5Y Avg
-89.83%
Market Cap
$25.29M
Return on Invested Capital (ROIC)
-59.10%
TTM Avg
-35.54%
3Y Avg
-33.20%
5Y Avg
-24.47%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | $27.78M | -103.04% | -86.52% | -75.92% | -70.96% |
| InspireMD, Inc. (NSPR)vs › | $28.10M | -153.04% | -84.65% | -78.92% | -71.84% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.49M | -109.29% | -89.70% | -72.19% | -61.37% |
| OneMedNet Corporation (ONMD)vs › | $29.16M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -99.36% | -324.14% | -260.84% | -230.57% |
| Context Therapeutics Inc. (CNTX)vs › | $29.58M | -126.84% | -48.51% | -88.12% | -74.86% |
| GridAI Technologies Corp. (GRDX)vs › | $30.09M | -42.23% | -23.50% | -191.16% | -191.16% |
| CervoMed Inc. (CRVO)vs › | $30.14M | -135.73% | -98.73% | -101.28% | -89.83% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.29M | -59.10% | -35.54% | -33.20% | -24.47% |
| BeyondSpring Inc. (BYSI)vs › | $30.31M | N/A | -54.98% | -73.47% | -75.57% |
ROIC
-103.0%
ROE
-65.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -103.04% |
| 2026-03-31 | -80.30% |
| 2025-12-31 | -72.70% |
| 2025-09-30 | -78.98% |
| 2025-06-30 | -97.57% |
| 2025-03-31 | -85.89% |
| 2024-12-31 | -123.05% |
| 2024-09-30 | -115.89% |
| 2024-06-30 | -69.07% |
| 2024-03-31 | -28.43% |
| 2023-12-31 | -40.45% |
| 2023-09-30 | -46.43% |
| 2023-06-30 | -45.19% |
| 2023-03-31 | -126.62% |
| 2022-12-31 | -93.49% |
| 2022-09-30 | -98.94% |
| 2022-06-30 | -54.36% |
| 2022-03-31 | -35.75% |
| 2021-12-31 | -23.66% |
| 2021-09-30 | -10.60% |
| 2021-06-30 | -59.77% |
| 2021-03-31 | -39.73% |
| 2020-12-31 | -29.68% |
| 2020-09-30 | -28.81% |
| 2020-06-30 | -135.76% |
| 2020-03-31 | -100.77% |
| 2019-12-31 | -83.14% |
| 2019-09-30 | -90.77% |
| 2019-06-30 | -77.06% |
| 2019-03-31 | -147.50% |
| 2018-12-31 | -127.86% |
| 2018-09-30 | -154.77% |
| 2018-06-30 | -97.20% |
| 2018-03-31 | -75.45% |
| 2017-12-31 | -57.88% |
| 2017-09-30 | -47.22% |
| 2017-06-30 | -51.96% |
| 2017-03-31 | -45.40% |
| 2016-12-31 | -38.33% |
| 2016-09-30 | -32.73% |
| 2016-06-30 | -29.55% |
| 2016-03-31 | -22.23% |
| 2015-12-31 | -26.63% |
| 2015-09-30 | -19.03% |
| 2015-06-30 | -32.32% |
| 2015-03-31 | -20.28% |
| 2014-12-31 | -13.29% |
| 2014-09-30 | -140.11% |
